MY LUNG CANCER CARE PLAN

Similar documents
UNDERSTANDING SQUAMOUS CELL LUNG CANCER

IMMUNOTHERAPY FOR THE TREATMENT OF LUNG CANCER

Dr. Andres Wiernik. Lung Cancer

TARGETED THERAPY FOR LUNG CANCER. Patient and Caregiver Guide

Charles Mulligan, MD, FACS, FCCP 26 March 2015

Guide to Understanding Lung Cancer

Personalized Therapies for Lung Cancer. Questions & Answers

LIVING WITH A DIAGNOSIS OF LUNG CANCER

Lara Kujtan, MD; Abdulraheem Qasem, MD

Cancer Survivorship NEURO-ONCOLOGY PATIENT SURVIVORSHIP PLAN. Resources and Tools for the Multidisciplinary Team

:00-13:00 Industry Satellite Symposium 1 Room A. 13:00-13:30 Welcome reception Hall 1. 13:30-13:45 Opening and welcome Room B

Documenting the journey

IMMUNOTHERAPY FOR THE TREATMENT OF LUNG CANCER

lung adenocarcinoma What you need to know about... TYPES OF LUNG CANCER

Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010

A Clinical Context Report

Case Studies. Ravi Salgia, MD, PhD

Treatment of oligometastatic NSCLC

October 12 13, 2018 New York Marriott Marquis New York, New York. The premier conference for annual updates in lung cancer. 23rd Annual Conference

squamous cell lung cancer

Infrastructure for Clinical Data Exchange

Logistics of Alchemist Screening Trial A Shauna Hillman, Statistician Chelsea Schultz, Data Manager Alliance SDC

1. Q: What has changed from the draft recommendations posted for public comment in November/December 2011?

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology

LUNG CANCER. Agnieszka Słowik, MD. Department of Oncology, University Hospital in Cracow Jagiellonian University

Non-Small Cell Lung Cancer:

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment with Targeted Tyrosine Kinase Inhibitors

NCCN Non-Small Cell Lung Cancer V Meeting June 15, 2018

RADIATION THERAPY RADIATION THERAPY. In this section, you will learn about:

Non-Small Cell Lung Cancer. Trusted Information to Help Manage Your Care from the American Society of Clinical Oncology

Lung Cancer Epidemiology. AJCC Staging 6 th edition

LUNG CANCER TREATMENTS UPDATED MAY What you need to know about... targeted therapy

Making a plan can help you be confident about your journey with EGFR+ lung cancer.

Your Medical Details and Treatment Tracker. About You

Living With Lung Cancer. Patient Education Guide

Traditional Approaches to Treating NSCLC, Part 2: Neoadjuvant Combined Modality, Locally Advanced, and Metastatic NSCLC

SIDE EFFECTS SIDE EFFECTS. In this section, you will learn about: Managing your side effects Tracking your side effects

Lung Cancer Genetics: Common Mutations and How to Treat Them David J. Kwiatkowski, MD, PhD. Mount Carrigain 2/4/17

Breast Cancer Survivor Treatment Summary and Plan

11/21/ M with LUL Mass Case Presentation / Round Table Discussion. Multiple-choice question What stage is this tumor?

Good Samaritan Oncology Services. Vincennes, Indiana

RADIATION THERAPY RADIATION THERAPY. In this section you will learn about:

Post-Induction PET Does Not Correlate with Persistent Nodal Disease or Overall Survival in Surgically Treated Stage IIIA Non-Small Cell Lung Cancer

Thoracic Surgery; An Overview

Unparalleled access to world-renowned cancer experts

Ask about your diabetes medicines

Adam J. Hansen, MD UHC Thoracic Surgery

A Cancer Patient s Guide to Radiation Therapy

immunotherapy a guide for the patient

RTOG Lung Cancer Committee 2012 Clinical Trial Update. Wally Curran RTOG Group Chairman

Doctor office visit checklist

Introduction: Overview of Current Status of Lung Cancer Predictive Biomarkers

CDx in oncology Prof. Christophe Le Tourneau, MD, PhD FEAM Geneva September 27, 2018

2017 Annual Report CANCER CENTER

IMMUNOTHERAPY FOR LUNG CANCER

An Interactive Guide to ALK+ Lymphoma. Our understanding of lung cancer has changed From one disease to many subtypes LCD

A GUIDE TO TREATMENT WHILE TAKING RYDAPT FOR ADVANCED SM

Thoracic and head/neck oncology new developments

Adjuvant Chemotherapy

The Expanding Value of Biomarkers in NSCLC Treatment

Non-Small Cell Lung Cancer. Trusted Information to Help Manage Your Care from the American Society of Clinical Oncology

NSCLC: Navigating New Therapies and Counseling Patients in Clinical Decisions. Final Outcomes Assessment September Genentech Grant ID: G-41513

PROFILING LUNG CANCER

Chair: W. Eberhardt, DE; S. Peters, CH. 12:00-13:00 Industry Satellite Symposium 1 (TBC) Room A. 13:30-13:45 Opening and Welcome Room B

Advancing Health Equity in Lung Cancer Outcomes

Lung cancer forms in tissues of the lung, usually in the cells lining air passages.

Although the international TNM classification system

State of the Art Treatment of Lung Cancer Ravi Salgia, MD, PhD

The Pathology of Neoplasia Part II

Lung Cancer. Trusted Information to Help Manage Your Care from the American Society of Clinical Oncology

Targeted Therapies in Lung Cancer Patient Forum

The Challenge of Lung Cancer

LUNG CANCER. pathology & molecular biology. Izidor Kern University Clinic Golnik, Slovenia

Molecular Testing Updates. Karen Rasmussen, PhD, FACMG Clinical Molecular Genetics Spectrum Medical Group, Pathology Division Portland, Maine

A GUIDE TO STARTING TREATMENT

None

Lung Cancer Non-small Cell Local, Regional, Small Cell, Other Thoracic Cancers: The Question Isn t Can We, but Should We

Lung and Aerodigestive malignancies

New Frontiers in Lung Cancer Detection, Diagnosis, and Treatment John Wells, MD MS Shyam Paryani, MD MS MHA First Radiation and

Immunotherapy and Lung Cancer

Patient Intake Assessment Tools for Navigation

Treatment of Clinical Stage I Lung Cancer: Thoracoscopic Lobectomy is the Standard

ALCHEMIST. Adjuvant Lung Cancer Enrichment Marker Identification And Sequencing Trials

EGFR-TARGETED THERAPIES FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) Pocket Guide

Management of advanced non small cell lung cancer

This online (electronic) survey contains twenty four simple questions. Those marked with an asterisk (*) must be answered.

Lung Cancer. Current Therapy JEREMIAH MARTIN MBBCh FRCSI MSCRD

Lung Cancer. Understanding your diagnosis cancer.ca

WELLNESS INITIATIVE NOW

LUNG CANCER PATHOLOGY: UPDATE ON NEUROENDOCRINE LUNG TUMORS

Lung Cancer Case Study

Retrospective analysis to determine the use of tissue genomic analysis to predict the risk of recurrence in early stage invasive breast cancer.

Exploring Personalized Therapy for First Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)

Clinical utility of precision medicine in oncology

Read, Interpret, and Communicate Test Results

Personal Calendar Tracker

Lung Cancer in Octogenarians: Factors Affecting Morbidity and Mortality After Pulmonary Resection

Small cell lung cancer (SCLC), which represents 20%

Advances in Pathology and molecular biology of lung cancer. Lukas Bubendorf Pathologie

Understanding surgery

Transcription:

MY LUNG CANCER CARE PLAN MANAGE DIAGNOSIS TRACK TREATMENTS & APPOINTMENTS MONITOR SYMPTOMS FREE TO BREATHE SUPPORT LINE (844) 835-4325 A FREE resource for lung cancer patients & caregivers

We are Free to Breathe. We are a partnership of lung cancer survivors, advocates, researchers, healthcare providers and industry leaders. We are united in the belief that every person with lung cancer deserves a cure. To learn more about lung cancer, refer to our free educational patient booklet Living with a Diagnosis of Lung Cancer. Order your free copy at freetobreathe.org LIVING WITH A DIAGNOSIS OF LUNG CANCER

Patient Information Name: Primary care doctor: Date diagnosed: Contact: As applicable: Medical oncologist: Radiation oncologist: Thoracic surgeon: Nurse/Patient navigator: Social worker: : Contact: Contact: Contact: Contact: Contact: Contact: medical conditions: Known allergies: DOWNLOAD THIS RESOURCE at freetobreathe.org/care-plan

About My Lung Cancer Lung cancer type: Small cell lung cancer (SCLC) Non-small cell lung cancer (NSCLC) Adenocarcinoma Biomarker test results EGFR T790M mutation KRAS PD-L1 ALK BRAF mutation ROS1 Squamous Biomarker test results PD-L1 (fill in): Large cell (fill in) Stage: Stage: Limited stage Extensive stage IA IIIA IB IIIB IIA IV IIB Date of initial biopsy: Date of follow-up biopsy: Date of plasma test for EGFR mutations, including T790M:

Treatment Plan Recommended treatment: Surgery Radiation Immunotherapy Chemotherapy Targeted therapy Treatment notes: Clinical trial recommended? Yes No Potential clinical trials & notes: Contact: LEARN ABOUT LUNG CANCER TREATMENT at freetobreathe.org/lung-cancer-info

Surgery Date scheduled: Where to go: Type: Wedge resection Lobectomy Segmentectomy Pneumonectomy Pre-surgery instructions: Post-surgery instructions: Surgery notes:

Radiation Therapy Start date: Where to go: Radiation type: Purpose: End date: Location in body: Side effects to watch for: Radiation therapy notes: LEARN ABOUT LUNG CANCER TREATMENT at freetobreathe.org/lung-cancer-info

Chemotherapy/Targeted Therapy/Immunotherapy/ Where to go: Treatment contact: Therapy regimen: Drug: Administered: (IV or pill) Dose: Start date: Treatment schedule & details:

Side effects to watch for: Therapy notes: LEARN ABOUT LUNG CANCER TREATMENT at freetobreathe.org/lung-cancer-info

Additional and Supportive Care/Side Effect Management Treatment: Example: Treatment XYZ How administered?: Dose (if applicable): Treatment schedule: Purpose: Orally 10 mg Twice daily Anti-nausea

Clinical Trials Find a clinical trial at freetobreathe.org/clinical-trials Clinical trial contact: Emergency/after-hours contact: Study name & number: Where to go: Drugs involved: What is being tested? Clinical trial notes: DOWNLOAD THIS RESOURCE at freetobreathe.org/care-plan

Additional Assistance Needed Find helpful resources at freetobreathe.org/resources Caregiver support Complementary therapy Emotional/mental health Employee rights Exercise/physical therapy Fertility consultation Financial advice/assistance Insurance assistance Nutritional counseling Pain management Respiratory health Relationship counseling Sexual health Smoking cessation : The Free to Breathe Support Line is a FREE resource for patients & caregivers. Call us Monday-Friday between 8am-4pm CDT: (844) 835-4325 toll-free

General Notes DOWNLOAD THIS RESOURCE at freetobreathe.org/care-plan

Symptom Tracker Dates: Symptom: What was done to help: Notes: Example: April 25-28 Shortness of breath Doctor prescribed inhaler Used as needed

Dates: Symptom: What was done to help: Notes: DOWNLOAD THIS RESOURCE at freetobreathe.org/care-plan

Symptom Tracker Dates: Symptom: What was done to help: Notes: Example: April 25-28 Shortness of breath Doctor prescribed inhaler Used as needed

Dates: Symptom: What was done to help: Notes: DOWNLOAD THIS RESOURCE at freetobreathe.org/care-plan

DOWNLOAD THIS RESOURCE at freetobreathe.org/care-plan

DOWNLOAD THIS RESOURCE at freetobreathe.org/care-plan

DOWNLOAD THIS RESOURCE at freetobreathe.org/care-plan

DOWNLOAD THIS RESOURCE at freetobreathe.org/care-plan

DOWNLOAD THIS RESOURCE at freetobreathe.org/care-plan

DOWNLOAD THIS RESOURCE at freetobreathe.org/care-plan

DOWNLOAD THIS RESOURCE at freetobreathe.org/care-plan

DOWNLOAD THIS RESOURCE at freetobreathe.org/care-plan

DOWNLOAD THIS RESOURCE at freetobreathe.org/care-plan

DOWNLOAD THIS RESOURCE at freetobreathe.org/care-plan

DOWNLOAD THIS RESOURCE at freetobreathe.org/care-plan

DOWNLOAD THIS RESOURCE at freetobreathe.org/care-plan

We re always seeking ways to improve our resources for patients and families. If you have feedback on this booklet or any other patient resources from Free to Breathe, please write to info@freetobreathe.org, or call (608) 833-7905. If you need support, call the Free to Breathe Support Line at (844) 835-4325 toll-free, Monday through Friday. It is a completely free resource for patients with lung cancer and their families. Learn more at freetobreathe.org/support. FOR ADDITIONAL PATIENT RESOURCES visit freetobreathe.org This resource provided with support from

we are FREE TO BREATHE Free to Breathe 1 Point Place, Suite 200 Madison, WI 53719 P (608) 833-7905 F (608) 833-7906 freetobreathe.org Free to Breathe Support Line: (844) 835-4325 toll free October 2017 US-15249 Last Updated 10/17